![Gavin David Clark](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gavin David Clark
Direttore/Membro del Consiglio presso Lamellar Biomedical Ltd.
Posizioni attive di Gavin David Clark
Società | Posizione | Inizio | Fine |
---|---|---|---|
Lamellar Biomedical Ltd.
![]() Lamellar Biomedical Ltd. Pharmaceuticals: MajorHealth Technology Lamellar Biomedical Ltd. manufactures basic pharmaceutical products. The firm's offers lamellasomes, a synthetic substance that mimics the actions lamellar bodies and provides treatment for respiratory diseases, such as cystic fibrosis. The company was founded in 2006 and is headquartered in Bellshill, the United Kingdom. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Gavin David Clark
Precedenti posizioni note di Gavin David Clark
Società | Posizione | Inizio | Fine |
---|---|---|---|
GlycoForm Ltd.
![]() GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | Corporate Officer/Principal | 01/01/2008 | 31/08/2011 |
Tibotec Pharmaceuticals | Corporate Officer/Principal | - | - |
GlaxoWellcome /Pharmocology Unit/ | Corporate Officer/Principal | 01/01/1994 | - |
JOHNSON & JOHNSON | Corporate Officer/Principal | - | - |
Procela Partners | Fondatore | - | - |
Pintex Pharmaceuticals, Inc.
![]() Pintex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pintex Pharmaceuticals, Inc. used to discover and develop cancer therapeutics. The company used to discover and commercialize new antibiotics focused on drug resistance. Pintex Pharmaceuticals was founded by Walter Gilbert, Kung Ping Lu and Janusz Sowadski in 1999 and was headquartered in Watertown, MA. | Corporate Officer/Principal | - | - |
PLIVA dd
![]() PLIVA dd Pharmaceuticals: MajorHealth Technology PLIVA d.d. is a joint stock company incorporated and domiciled in the Republic of Croatia. The registered office is at Vukovarska 49, Zagreb. The Company is the parent of the PLIVA Group (“the Group”). The Group manufactures and supplies a wide range of pharmaceutical products as its core business. Non-core businesses consist of the manufacture and supply of DDDI products (diagnostics, disinfectants, dialysis, and infusions). | Corporate Officer/Principal | - | - |
PHYSIOMICS PLC | Corporate Officer/Principal | - | - |
░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ | - | - | |
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░ ░░ ░░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formazione di Gavin David Clark
University of Strathclyde | Undergraduate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 12 |
Stati Uniti | 5 |
Germania | 3 |
Posizioni
Corporate Officer/Principal | 18 |
Director/Board Member | 3 |
Founder | 2 |
Settori
Health Technology | 17 |
Commercial Services | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 4 |
---|---|
JOHNSON & JOHNSON | Health Technology |
BAYER AG | Health Technology |
ACUMEN PHARMACEUTICALS, INC. | Health Technology |
PHYSIOMICS PLC | Commercial Services |
Aziende private | 17 |
---|---|
Pintex Pharmaceuticals, Inc.
![]() Pintex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pintex Pharmaceuticals, Inc. used to discover and develop cancer therapeutics. The company used to discover and commercialize new antibiotics focused on drug resistance. Pintex Pharmaceuticals was founded by Walter Gilbert, Kung Ping Lu and Janusz Sowadski in 1999 and was headquartered in Watertown, MA. | Health Technology |
Janssen-Cilag Ltd.
![]() Janssen-Cilag Ltd. Pharmaceuticals: MajorHealth Technology Janssen-Cilag Ltd. provides pharmaceutical products and services. It offers medicines that can treat serious health conditions such as schizophrenia, epilepsy, multiple myeloma, and human immunodeficiency virus/acquired immunodeficiency syndrome. The firm's other key areas of activity include pain management, gastroenterology, fungal infections, women’s health, neurology, and anaemia. The company was founded on October 19, 1971 and is headquartered in High Wycombe, the United Kingdom. | Health Technology |
RioTech Pharmaceuticals Ltd.
![]() RioTech Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology RioTech Pharmaceuticals Ltd. develops novel therapeutic drugs for hepatitis C virus. The company was founded on Nov 5, 2001 by Graham Foster, Adrian V. S. Hill, Peter Karayiannis, Howard David Thomas and Mark R. Thursz and is headquartered in Horsham, the United Kingdom. | Health Technology |
PLIVA dd
![]() PLIVA dd Pharmaceuticals: MajorHealth Technology PLIVA d.d. is a joint stock company incorporated and domiciled in the Republic of Croatia. The registered office is at Vukovarska 49, Zagreb. The Company is the parent of the PLIVA Group (“the Group”). The Group manufactures and supplies a wide range of pharmaceutical products as its core business. Non-core businesses consist of the manufacture and supply of DDDI products (diagnostics, disinfectants, dialysis, and infusions). | Health Technology |
GlaxoWellcome /Pharmocology Unit/ | Commercial Services |
PowderMed Ltd.
![]() PowderMed Ltd. Pharmaceuticals: MajorHealth Technology PowderMed Ltd. develops immunotherapeutic products. It focuses on the clinical development and manufacture of therapeutic and prophylactic DNA-based vaccines for viral diseases and cancer. The company has 4 clinical and 3 pre-clinical stage projects. The company was founded February 25, 2004 by Dr. Clive Dix & Dr. Beadle and is headquartered at Oxford, The United Kingdom. | Health Technology |
GlycoForm Ltd.
![]() GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | Health Technology |
Angel Biotechnology Holdings Plc
![]() Angel Biotechnology Holdings Plc BiotechnologyHealth Technology Angel Biotechnology Holdings Plc operated as a contract bio-manufacturing company that offers process development, pre-GMP and cGMP manufacturing services. The company specialized in offering the cGMP manufacture of advanced biologics including stem cells, cell therapies, recombinant proteins, antibodies and viruses for clinical trial use and commercial sale. It also provided development and manufacturing support for production of biologics working from laboratory scale to development of a robust manufacturing process. Angel Biotechnology was founded on December 7, 2000 and was headquartered in Edinburgh, the United Kingdom. | Health Technology |
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Affimed NV Niederlassung Deutschland
![]() Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Health Technology |
Lamellar Biomedical Ltd.
![]() Lamellar Biomedical Ltd. Pharmaceuticals: MajorHealth Technology Lamellar Biomedical Ltd. manufactures basic pharmaceutical products. The firm's offers lamellasomes, a synthetic substance that mimics the actions lamellar bodies and provides treatment for respiratory diseases, such as cystic fibrosis. The company was founded in 2006 and is headquartered in Bellshill, the United Kingdom. | Health Technology |
NeuroCure Ltd.
![]() NeuroCure Ltd. BiotechnologyHealth Technology NeuroCure Ltd. manufactures drugs to cure psychiatric and central nervous system diseases. It has programs available for out-licensing and its licensing novel use inventions supported by clinical data and with novel formulations. The company was founded by Ted Dinan and Peter Daly in 2003 and is headquartered in Dublin, Ireland. | Health Technology |
Procela Partners | |
Tibotec Pharmaceuticals | |
MGB Biopharma Ltd.
![]() MGB Biopharma Ltd. BiotechnologyHealth Technology MGB Biopharma Ltd. develops anti-infective medicines. Its lead candidate, MGB-BP-3, is an antibacterial which is active against important multi-resistant and susceptible Gram-positive pathogens. The firm develops an oral formulation of MGB-BP-3 for the treatment of clostridium difficile associated disease. The company was founded by Miroslav Ravic, Gavin David Clark and Raymond Spencer in 2010 and is headquartered in Glasgow, the United Kingdom. | Health Technology |
Immunovo BV
![]() Immunovo BV BiotechnologyHealth Technology Immunovo BV develops immune therapeutics in the field of oncology. The firm's research focuses on therapeutic vaccines based on synthetic peptide antigens for which the company applies the novel and proprietary techniques in synthetic immunogen development. Its products include Sclerostin, PD1, PEPA10-adj, Gastrine, VEGF, and GnRH. The company was founded in 2009 and is headquartered in ‘s-Hertogenbosch, the Netherlands. | Health Technology |
Netherlands Translational Research Center BV
![]() Netherlands Translational Research Center BV Medical/Nursing ServicesHealth Services Netherlands Translational Research Center BV develops small molecule drug leads and preclinical candidates for cancer, autoimmune and Parkinson diseases. Its product NFK GreenScreen plays an important role in immune modulation and neurodegenerative disease. The firm also offers Oncolines, OncolinesProfiler, SynergyFinder, ResidenceTimer and EntropySelect services. The company was founded by Guido J. R. Zaman and Rogier C. Buijsman in June 2011 and is headquartered in Oss, the Netherlands. | Health Services |
- Borsa valori
- Insiders
- Gavin David Clark
- Esperienza